ASCO GU: MVAC Safe Alternative for Neoadjuvant Treatment of Invasive Bladder Cancer
In a trial of 64 patients, neoadjuvant chemotherapy with methotrexate, doxorubicin, vinblastine, and cisplatin (MVAC) had promising results in the treatment of muscle-invasive bladder cancer.
Source: Cancer Network - Category: Cancer & Oncology Source Type: news
More News: Bladder Cancer | Cancer | Cancer & Oncology | Chemotherapy | Methotrexate | Neoadjuvant Chemotherapy Therapy | Neoadjuvant Therapy